Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business
Paul Sandle

UK detects South African coronavirus variant in people with no travel links

A public health information message is seen at a bus stop in West Ealing as the South African variant of the novel coronavirus is reported in parts of the United Kingdom amid the spread of the coronavirus disease (COVID-19), London, Britain, February 1, 2021. REUTERS/Toby Melville

Eleven people in different regions of England have tested positive for the South African coronavirus variant without having any links to people who have travelled, prompting mass testing in the areas to contain the outbreak.

Britain, with the world's fifth-highest COVID-19 death toll, has moved to tighten its borders out of concern that new variants of the virus will undermine its vaccination drive.

A worker collects a swab from a car window at a test centre in Goldsworth Park, as the South African variant of the novel coronavirus is reported in parts of Surrey, in Woking, Britain, February 1, 2021. REUTERS/Hannah McKay

To contain the new outbreaks, residents in eight areas of the country will now be tested whether or not they are showing symptoms, a process known as "surge testing".

There are about 10,000 people in each area. Three are in London, two in the southeast, one in central England, one in the east and another in the northwest.

Health minister Matt Hancock said those in the affected areas needed to comply with the request to be tested, even if they are asymptomatic, to break any chain of transmission.

A worker collects a swab from a car window at a test centre in Goldsworth Park, as the South African variant of the novel coronavirus is reported in parts of Surrey, in Woking, Britain, February 1, 2021. REUTERS/Hannah McKay

"There's currently no evidence to suggest this variant is any more severe," he said. "But we need to come down on it hard, and we will."

Positive tests in the areas will be sequenced to identify any further spread of the variant.

All viruses mutate, and scientists have identified several variants of the coronavirus found to be more transmissible than the original strain.

Sign hangs at a test centre in Goldsworth Park, as the South African variant of the novel coronavirus is reported in parts of Surrey, in Woking, Britain, February 1, 2021. REUTERS/Hannah McKay

Their emergence has raised questions over whether vaccines will still prove effective.

Public Health England said it has identified a total of 105 cases of the South African variant since Dec 22.

Scientists have said it appears to be more transmissible, but there is no evidence that it causes more severe disease. However, several laboratory studies have found that it reduces vaccine and antibody therapy efficacy.

FILE PHOTO: Healthcare workers transport a patient at the Royal London Hospital, as the spread of the coronavirus disease (COVID-19) continues, in London, Britain, January 26, 2021. REUTERS/Hannah McKay

Simon Clarke, associate professor in cellular microbiology at the University of Reading, said there was emerging evidence to suggest the variant was less susceptible to immunity induced by the current crop of vaccines.

"The discovery of a handful of cases with no links to travel to Africa indicates that it might be more widespread in the community than previously thought," he said.

"This spread, even if small in scale, needs to be brought under control quickly, so Public Health England's house-to-house checks and intensive testing are the right thing to do."

Public Health England's Managing Director Susan Hopkins said the cases did not appear linked.

"They're more likely to be related to somebody who potentially had asymptomatic infection when they came in from abroad," she said at a news conference.

Britain is battling a new wave of COVID-19 turbocharged by the emergence in September of a more transmissable variant found in the southeast of England. The country's official death toll passed 100,000 last week.

Britain is, however, making rapid progress in its vaccination programme, with nearly 9.3 million people having received the first shot of either the Pfizer-BioNTech or Oxford-AstraZeneca shot.

(Reporting by Kate Holton, Michael Holden and Paul Sandle; Editing by Estelle Shirbon, Timothy Heritage and David Goodman)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.